Altermune Gets Boost with $7M Seed Funding via Loxbridge JV

Founded based on an unusual idea for combating multiresistant pathogens, Altermune Technologies LLC is getting a business makeover, inking a joint venture deal with Loxbridge Research LLP that brings the biotech $7 million in seed funding and allows the firm's scientists to focus on advancing the technology.